Literature DB >> 21035709

Cervical cystic lymphangioma in a patient with blue rubber bleb nevus syndrome: clinical case report and review of the literature.

Elena Marín-Manzano1, Agustin Utrilla López, Enrique Puras Magallay, Carmen Cuesta Gimeno, J L Marín-Aznar.   

Abstract

We present the case of a 9-year-old boy diagnosed with blue rubber bleb nevus syndrome, who showed a very large left cervical cystic lymphangioma. He was previously subjected to various treatments for lesions in the intestinal tract including blood transfusions for anemia, sclerosis, enterotomies or resections. The tumor was resected without any complications and the anatomopathologic report confirmed this diagnosis. The blue cavernous hemangioma syndrome (or blue rubber bleb nevus syndrome) is a rare disease characterized by cavernous angiomas involving the skin and gastrointestinal tract. Several cases of cystic lymphangiomas associated with this syndrome have been published recently and lymphomatous differentiation has been identified in the cells of cutaneous lesions. Given their common embryological origin, we underscore the importance of bearing in mind that it is possible for different types of vascular malformations to coexist in the same patient.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21035709     DOI: 10.1016/j.avsg.2010.02.052

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  An Unusual Cause of Facial Rash.

Authors:  Arjun Gupta; Harris Naina
Journal:  J Gen Intern Med       Date:  2015-08       Impact factor: 5.128

Review 2.  Blue rubber bleb nevus syndrome: a case report and literature review.

Authors:  Xue-Li Jin; Zhao-Hong Wang; Xi-Bin Xiao; Lian-Sheng Huang; Xiao-Ying Zhao
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

3.  Sirolimus alternative to blood transfusion as a life saver in blue rubber bleb nevus syndrome: A case report.

Authors:  Ke-Ling Wang; Shu-Fang Ma; Ling-Yu Pang; Meng-Na Zhang; Lin-Yan Hu; Meng-Jia Liu; Li-Ping Zou
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.